Crescent Capital BDC (CCAP) to Release Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is projected to post its quarterly earnings results after the market closes on Wednesday, February 19th. Analysts expect Crescent Capital BDC to post earnings of $0.56 per share and revenue of $47.27 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.07. The firm had revenue of $51.63 million during the quarter, compared to analysts’ expectations of $48.76 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. During the same quarter in the previous year, the company earned $0.59 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Up 0.5 %

Shares of NASDAQ CCAP opened at $19.67 on Wednesday. The stock has a market cap of $728.97 million, a P/E ratio of 7.71 and a beta of 0.81. The firm has a 50 day moving average price of $19.43 and a 200 day moving average price of $18.80. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. Crescent Capital BDC has a 52-week low of $16.02 and a 52-week high of $20.03.

Crescent Capital BDC Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st were issued a dividend of $0.42 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.68 dividend on an annualized basis and a yield of 8.54%. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s payout ratio is currently 65.88%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Keefe, Bruyette & Woods boosted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. Wells Fargo & Company upped their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Crescent Capital BDC presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.33.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.